Latest Distributions News

Oldfields Holdings announces the resignation of its Chairman, Managing Director, CEO, and a Non-Executive Director, triggering an interim leadership phase as the company searches for new executives.

KALiNA Power has advanced its Canadian AI data centre power portfolio with strategic site sales, partnerships, and a $1.5 million capital raise to fund development milestones.

Cann Group Limited reported a 20% rise in Q3 production and improved operating cash flow, while navigating a 38% sales dip due to order timing. The company bolstered its balance sheet with new funding and expanded its Botanitech distribution network.

Australian Bond Exchange Holdings (ASX: ABE) reported a strong $3.6 billion trading volume for Q3 FY25 and announced a strategic partnership with ViewTrade Australia, while securing $1.8 million in funding to support its growth trajectory.

Duxton Farms reported a strategic property acquisition in the Northern Territory alongside a $38 million sale of its Kentucky aggregation, navigating challenging weather and mixed commodity prices in Q3 FY2025.

Pure Resources has entered a strategic alliance with SSH Group to fast-track development of its Reedy Creek Garnet Project, supported by promising metallurgical test results and exploration progress.

Volt Group Limited reported a robust 26.8% revenue increase in Q1 FY25, driven by strong performances in its EcoQuip and Wescone divisions, alongside promising advances in its ATEN Waste Heat to Power technology.

Elixinol Wellness reported a 13.7% year-on-year revenue increase in Q1 FY25, despite a softer quarter compared to record Q4, with ecommerce momentum and strategic initiatives setting the stage for margin recovery and growth in H2.

Avecho Biotechnology has inked a decade-long exclusive licensing agreement with Sandoz for its pharmaceutical-grade cannabidiol capsule targeting insomnia in Australia, backed by a US$3 million upfront payment and promising milestone and royalty streams.

Indiana Resources reports significant high-grade gold assay results extending the Minos Southwest Zone and deepening mineralisation, alongside a strong cash position and corporate developments including a proposed capital return.

Little Green Pharma reported a robust 40% revenue increase for FY25, driven by strong European sales and the strategic acquisition of Health House. The company also advanced clinical research and secured new therapy funding, positioning itself for continued growth.

Tissue Repair Limited reports progress in its Phase 3 clinical trials for TR987® despite enrollment delays caused by US regulatory disruptions, while TR Pro+® sales hit record highs and manufacturing scale-up advances.